Migraine Clinical Trials in Phoenix, Arizona

7 studies are recruiting for migraine in Phoenix, Arizona right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

   This is a double-blind, randomized, multicenter, outpatient evaluation of the safety and efficacy of elismetrep, as compared with placebo, in the treatment of moderate or severe of migraine.

   Stage

   Phase 3

   Ages

   18 to 75

   Site

   Velocity Clinical Research, Phoenix, Phoenix, Arizona

   Locations

   72 in total

   Run by

   TriGemX Bio, Inc.

   See if you can join NCT07816367 on ClinicalTrials.gov

2. Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

   This goal of this study is to compare three medications used for migraine preventive treatment. This study will compare atogepant, a newer migraine preventive medication, with two older preventive medications, topiramate and propranolol. It will be determined if one works better and is more tolerab…

   Stage

   Phase 4

   Ages

   18 to 70

   Site

   Mayo Clinic Arizona, Phoenix, Arizona

   Locations

   37 in total

   Run by

   Mayo Clinic

   See if you can join NCT06972056 on ClinicalTrials.gov

3. Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients

   This study is testing an investigational inhaled migraine medication to see how well it works, how safe it is, and how well people tolerate it. Adults with migraine will receive both the study medication (ASY202) and a placebo (inactive treatment) at different times during the study. Neither partic…

   Stage

   Phase 2

   Ages

   18 to 65

   Site

   Arizona Research Center, Phoenix, Arizona

   Locations

   20 in total

   Run by

   Aspeya, Inc.

   See if you can join NCT07646613 on ClinicalTrials.gov

4. Responding With Evidence and Access for Childhood Headaches

   This comparative effectiveness study will clarify current first-line preventive treatment approaches for use by neurologists, psychologists, and primary care providers in the context of real world care, and will demonstrate the feasibility of Cognitive Behavioral Therapy (CBT) via telehealth for yo…

   Stage

   Not phased

   Ages

   10 to 17

   Site

   Phoenix Children's Hospital - Barrow Neurological Institute, Phoenix, Arizona

   Locations

   15 in total

   Run by

   Children's Hospital Medical Center, Cincinnati

   See if you can join NCT05889624 on ClinicalTrials.gov

5. Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications

   Zavegepant (Zavzpret) is approved for the acute treatment of migraine with or without aura in the US. The purpose of this study is to investigate the effectiveness and tolerability of zavegepant for the acute treatment of migraine attacks amongst participants who are using calcitonin gene-related p…

   Stage

   Phase 4

   Ages

   18 and older

   Site

   Mayo Clinic in Arizona, Phoenix, Arizona

   Run by

   Mayo Clinic

   See if you can join NCT06401642 on ClinicalTrials.gov

6. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

   Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in children. The purpose of this study is to evaluate how s…

   Stage

   Phase 3

   Ages

   6 to 17

   Site

   Velocity Clinical Research - Phoenix /ID# 274478, Phoenix, Arizona

   Locations

   129 in total

   Run by

   AbbVie

   See if you can join NCT05125302 on ClinicalTrials.gov

7. Determining the Utility of a Behavioral Intervention in Chronic Migraine

   This proposal will involve a pilot study to evaluate the feasibility, acceptability, and outcomes of a lifestyle behavior protocol in managing chronic migraine. Additionally, the proposal will investigate biomolecules that are uniquely involved in chronic migraine patients who respond to the protoc…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Mayo Clinic, Phoenix, Arizona

   Run by

   Mayo Clinic

   See if you can join NCT05415020 on ClinicalTrials.gov